Allergan’s AVYCAZTM potent in vitro activity against certain common Enterobacteriaceae pathogens

Allergan’s researchers have presented data at IDWeek from the International Network for Optimal Resistance Monitoring (INFORM) program that monitors the prevalence of resistant bacteria and changing trends of resistance, as well as the in vitro activity of antibiotics against these pathogens.

Read more